| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BO Brian Oliveira Clear Street Group Inc. | 22,221 | $236,766.66 | $238,431.33 | $1,664.67 | 0.7% |
| NASDAQ (NMS) Exchange | US Country |
Oaktree Acquisition Corp. III Life Sciences is a blank check company, specifically formed with the primary objective of facilitating a business merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The inception of this company dates back to 1995, and since then, it has been strategically headquartered in Los Angeles, California. With its unique positioning within the business and financial landscapes, Oaktree Acquisition Corp. III Life Sciences aims to leverage its expertise and resources to identify and engage with potential business partners within the life science sector, among others, to foster growth, innovation, and value creation for its stakeholders.
Oaktree Acquisition Corp. III Life Sciences, by its nature as a blank check company, does not offer traditional products or services. Instead, its offerings can be categorized broadly into investment and acquisition opportunities:
This service involves identifying, evaluating, and executing merger and acquisition opportunities with companies primarily in the life sciences sector. Oaktree Acquisition Corp. III Life Sciences uses its strategic position and resources to find suitable targets for mergers or acquisitions, aiming to create synergies and enhance shareholder value.
Part of its services includes facilitating capital stock exchanges. This involves transactions where shares of the company are exchanged for shares of another company, typically as part of a broader merger or acquisition strategy. It allows for a seamless transition in ownership and investment realignment in accordance with strategic goals.
Another key service area is the acquisition of assets, where Oaktree Acquisition Corp. III Life Sciences seeks out valuable assets from other companies or entities for purchase. This process is critical for growth and expansion, particularly in targeting specific competencies or market segments within the life sciences and related industries.
The company also engages in stock purchase agreements, where it buys the stock of other companies as part of its strategic investment approach. This method allows for direct investment in promising companies within the life sciences sector, supporting their growth and benefiting from their success.
Supporting reorganization or similar business combination activities falls within the purview of Oaktree Acquisition Corp. III Life Sciences. The goal is to restructure or combine businesses in a way that optimizes operations, reduces inefficiencies, and enhances overall business performance and value.